ENTASIS THERAPEUTICS HLDGS I's ticker is ETTX and the CUSIP is 293614103. A total of 22 filers reported holding ENTASIS THERAPEUTICS HLDGS I in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $771,000 | +27.2% | 350,345 | +8.2% | 0.00% | 0.0% |
| Q1 2022 | $606,000 | -14.4% | 323,845 | +0.2% | 0.00% | 0.0% |
| Q4 2021 | $708,000 | -32.2% | 323,345 | +3.5% | 0.00% | 0.0% |
| Q3 2021 | $1,044,000 | -0.2% | 312,545 | -20.2% | 0.00% | 0.0% |
| Q2 2021 | $1,046,000 | -37.8% | 391,629 | -50.2% | 0.00% | -50.0% |
| Q1 2021 | $1,683,000 | +34.5% | 786,606 | +55.3% | 0.00% | +100.0% |
| Q4 2020 | $1,251,000 | +154.8% | 506,389 | +110.3% | 0.00% | – |
| Q3 2020 | $491,000 | +70.5% | 240,841 | +147.2% | 0.00% | – |
| Q2 2020 | $288,000 | +209.7% | 97,446 | +177.6% | 0.00% | – |
| Q1 2020 | $93,000 | -26.2% | 35,103 | +38.7% | 0.00% | – |
| Q4 2019 | $126,000 | +20.0% | 25,300 | +42.9% | 0.00% | – |
| Q3 2019 | $105,000 | – | 17,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,349,953 | $8,046,000 | 2.52% |
| Novo Holdings A/S | 2,181,843 | $13,004,000 | 2.23% |
| Sofinnova Investments, Inc. | 1,180,178 | $7,034,000 | 0.64% |
| TPG Group Holdings (SBS) Advisors, Inc. | 2,041,496 | $12,168,000 | 0.09% |
| Eventide Asset Management | 392,513 | $2,288,000 | 0.08% |
| Blackstone Inc. | 1,623,405 | $9,675,000 | 0.06% |
| Granahan Investment Management | 141,012 | $840,000 | 0.05% |
| Janney Montgomery Scott LLC | 46,861 | $279,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 5,921 | $35,000 | 0.00% |
| BlackRock Inc. | 15,755 | $94,000 | 0.00% |